Ezz Lulu, the 5th yr medical student we've been hearing from is still at Al Shifa with other staff refusing to leave their patients. The hospital is being relentlessly attacked by israel. He will get killed. He's saying farewell. We will never forgive the world for any of this.

Over 10k protest towards the capital in St Paul Minnesota #free #Palestine

🩸The DETERMINATION trial "determined" that for patients with newly diagnosed multiple myeloma, RVD chemo + autologous marrow transplant prolonged PFS compared to RVD alone [NEJM]. See more summaries: LMTrials.com #MedEd #MedStudentTwitter #EBM #research #hematology

Can we do a better job of preventing ventilator acquired pneumonia? Ehrmann et al showed that 3 days of inhaled amikacin reduced the rates of VAP in patients ventilated >72 hrs. Original article: nejm.org/doi/full/10.10… #MedEd #MedTwitter #Medstudent #criticalcare #antibiotics

There are no approved targeted therapies for KRAS-mutant colorectal caner. Fakih et al just demonstrated that the TKRAS G12C inhibitor sotorasib + panitumumab improved PFS in metastatic colorectal cancer with KRAS G12C mutations. Published in NEJM nejm.org/doi/full/10.10…

Excited to present some of our work at #ASCO #GI24! Mayo Clinic Hematology-Oncology Fellowship

First update for 2024! We've added summaries for 4 more practice-changing trials to our website LMTrials.com. Thank you to all those who have suggested pertinent articles for us to include! #EBM #Medstudent #MedTwitter

The ORBITA-2 trial demonstrated that PCI was more effective than a placebo procedure at reducing anginal symptoms among patients with stable angina. Full article: nejm.org/doi/full/10.10… #Cardiotwitter #Cardiology #EBM #MedTwitter

📜The RENAAL trial was important in demonstrating the benefits of ARBs like losartan in protecting diabetic patients from progression of nephropathy 🫘 See more summaries at: LMTrials.com #EBM #MedEd #medstudenttwitter #clinicaltrials

Case study by Khalid Jazieh et al. examines unilateral ptosis caused by #ipilimumab and #nivolumab therapy doi.org/10.36401/JIPO-… Khalid Jazieh #immunotherapy #JIPO

#ASCO24 is special at a personal level! It is the first ASCO Annual Meeting to be attended with Khalid Jazieh . ASCO

Why target a mean arterial pressure (MAP) of 65 mmHg for most critically patients instead of a higher threshold? The SESISPAM trial answered that question! See more summaries at: LMTrials.com #EBM #clinicaltrial #medtwitter #medstudenttwitter #criticalcare

Two Phase 2 trials were recently published demonstrating that tirzepatide and survodutide both improved MASH, with mostly manageable side effects. The articles can be read here: nejm.org/doi/full/10.10… nejm.org/doi/full/10.10…

The FIRST time the afternoon prayer is called from the iconic Ummayad Mosque in Damascus after 54 years of the bloodthirsty Assad regime Al Jazeera’s reporter can’t help but cry John the Baptist (Prophet Yahya in Islam) is buried here. And so many rebels dreamt of praying here

الله أكبر ولله الحمد

#GI25 ASCO We're in that gap between the holidays🎄and GI-ASCO (if that matters to you😉) ➡️And, we're stuck here at home because of the snow🌨️ outside 📢So this is a perfect time to present my "Top Abstract Titles" that I will be looking out for🔍at ASCO GI

▫️يفتتح التسجيل في برنامج #البناء_المنهجي الدفعة السادسة بتاريخ 18 رجب 1446 الموافق 2025/1/18 بمشيئة الله تعالى. ▫️سيُنشَر رابط التسجيل على هذا الحساب وغيره من المنصات والحسابات في شبكات التواصل. ▫️تستمر مدة التسجيل لأسبوع ثم تنطلق المرحلة الدراسية التمهيدية الأساسية. ▫️بعد

Grateful to have our work on the genetic landscape of KRAS G12C-positive GI cancers and potential resistance mutations published! aacrjournals.org/clincancerres/…

New trials added!

🩸Do the results of the API-CAT trial change your anticoagulation (AC) practice? Patients with cancer and DVT/PE and at least 6 months of AC were assigned to receive apixaban at half or full dose. Half-dose was non-inferior at preventing VTE, and had lower bleeding risk. #EBM